| Dr Ralf K Kiehl, MD | |
|
214 14th Ave Sw, Sidney, MT 59270 | |
| (406) 488-2504 | |
| (406) 488-2553 |
| Full Name | Dr Ralf K Kiehl |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 38 Years |
| Location | 214 14th Ave Sw, Sidney, Montana |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760483788 | NPI | - | NPPES |
| 01592676 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 200385 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sidney Health Center | Sidney, MT | Hospital |
| Sheridan Memorial Hosptial | Plentywood, MT | Hospital |
| Glendive Medical Center | Glendive, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sidney Health Center | 0749181535 | 63 |
News Archive
There has been speculation in the press about the work to be carried out at the planned UK Centre for Medical Research and Innovation, a world-class facility which will deliver ground breaking new research.
A project taking the first steps towards ending the use of horses to treat diphtheria has succeeded.
Opexa Therapeutics, Inc., a biotechnology company developing a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the year ended December 31, 2011 and provided an overview of corporate developments during the last year.
Actelion Pharmaceuticals US, Inc. and the ENTELLIGENCE Steering Committee recognized four young researchers and their mentors for their efforts in advancing research in PAH. Each researcher will receive a 12-month mentored grant of up to $100,000 in support, funded through the ENTELLIGENCE program supported by Actelion. The announcement was made at an awards luncheon, during which the recipients of the 2011 awards gave an overview of their proposed work.
Roman gladiators ate a mostly vegetarian diet and drank ashes after training as a tonic. These are the findings of anthropological investigations carried out on bones of warriors found during excavations in the ancient city of Ephesos.
› Verified 9 days ago
| Entity Name | Sidney Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376617191 PECOS PAC ID: 0749181535 Enrollment ID: O20040115000513 |
News Archive
There has been speculation in the press about the work to be carried out at the planned UK Centre for Medical Research and Innovation, a world-class facility which will deliver ground breaking new research.
A project taking the first steps towards ending the use of horses to treat diphtheria has succeeded.
Opexa Therapeutics, Inc., a biotechnology company developing a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the year ended December 31, 2011 and provided an overview of corporate developments during the last year.
Actelion Pharmaceuticals US, Inc. and the ENTELLIGENCE Steering Committee recognized four young researchers and their mentors for their efforts in advancing research in PAH. Each researcher will receive a 12-month mentored grant of up to $100,000 in support, funded through the ENTELLIGENCE program supported by Actelion. The announcement was made at an awards luncheon, during which the recipients of the 2011 awards gave an overview of their proposed work.
Roman gladiators ate a mostly vegetarian diet and drank ashes after training as a tonic. These are the findings of anthropological investigations carried out on bones of warriors found during excavations in the ancient city of Ephesos.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ralf K Kiehl, MD 214 14th Ave Sw, Sidney, MT 59270-3521 Ph: (406) 488-2504 | Dr Ralf K Kiehl, MD 214 14th Ave Sw, Sidney, MT 59270 Ph: (406) 488-2504 |
News Archive
There has been speculation in the press about the work to be carried out at the planned UK Centre for Medical Research and Innovation, a world-class facility which will deliver ground breaking new research.
A project taking the first steps towards ending the use of horses to treat diphtheria has succeeded.
Opexa Therapeutics, Inc., a biotechnology company developing a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the year ended December 31, 2011 and provided an overview of corporate developments during the last year.
Actelion Pharmaceuticals US, Inc. and the ENTELLIGENCE Steering Committee recognized four young researchers and their mentors for their efforts in advancing research in PAH. Each researcher will receive a 12-month mentored grant of up to $100,000 in support, funded through the ENTELLIGENCE program supported by Actelion. The announcement was made at an awards luncheon, during which the recipients of the 2011 awards gave an overview of their proposed work.
Roman gladiators ate a mostly vegetarian diet and drank ashes after training as a tonic. These are the findings of anthropological investigations carried out on bones of warriors found during excavations in the ancient city of Ephesos.
› Verified 9 days ago
Dr. John Morgan, M.D. Radiology Medicare: May Accept Medicare Assignments Practice Location: 216 14th Ave Sw, Sidney, MT 59270 Phone: 406-488-2100 | |
Jennifer Adams, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 216 14th Ave Sw, Sidney, MT 59270 Phone: 406-488-2100 | |
Dr. Gregory Brian Faul, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 216 14th Ave Sw, Sidney, MT 59270 Phone: 406-488-2167 |